Skip to main content
Fig. 5 | European Radiology Experimental

Fig. 5

From: The TRUTH confirmed: validation of an intraindividual comparison of gadobutrol and gadoteridol for imaging of glioblastoma using quantitative enhancement analysis

Fig. 5

Comparison of quantitative enhancement (QE) maps for gadobutrol (a) and gadoteridol (b) reveals even very minor differences in contrast enhancement. In this case, the QE change map (c) shows that enhancement of the lesion rim (arrow) is slightly different between the agents. Purple indicates that enhancement is brighter after gadobutrol while yellow indicates that enhancement is brighter after gadoteridol

Back to article page